Mechanisms of cardiac dysfunction in diabetic cardiomyopathy: molecular abnormalities and phenotypical variants

Area of Science:

• Cardiology
• Metabolic Diseases
• Pathophysiology

Background:

• Diabetic cardiomyopathy (DCM) is a diabetes mellitus complication causing cardiac structural, functional, and metabolic changes.
• It leads to heart failure (HF) independent of other common cardiac conditions like hypertension or coronary artery disease.
• Metabolic dysregulation in diabetes, including hyperglycemia and insulin resistance, drives DCM pathogenesis.

Purpose of the Study:

• To provide a detailed analysis of the cellular and molecular mechanisms underlying DCM.
• To explore the metabolic pathways involved in the pathophysiology of diabetic heart disease.
• To discuss the different observed phenotypes of DCM and potential differences between Type 1 and Type 2 diabetes.

Main Methods:

• This review synthesizes current knowledge on DCM pathophysiology.
• It analyzes cellular and molecular mechanisms, including oxidative stress, inflammation, and apoptosis.
• Metabolic pathways and phenotypic variations in DCM are examined.

Main Results:

• Metabolic alterations in diabetes promote oxidative stress, inflammation, and apoptosis, leading to cardiac remodeling.
• Structural changes like cardiac stiffness, hypertrophy, and fibrosis contribute to heart dysfunction and heart failure.
• Distinct DCM phenotypes exist, with potential differences between Type 1 and Type 2 diabetes mellitus.

Conclusions:

• DCM involves complex cellular and molecular pathways driven by diabetes-induced metabolic changes.
• Further research is crucial to elucidate DCM mechanisms, identify therapeutic targets, and develop strategies to prevent or reverse its progression to heart failure.